SYRE Spyre Therapeutics, Inc. logo

SYRE Spyre Therapeutics, Inc.

Healthcare
$73.48+0.00%OpenMarket Cap: $4.44B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

4

Dispositions

27

Buy/Sell Ratio

0.15

Net Shares

-216,291

Shares Acquired

106,291

Shares Disposed

322,582

Total Bought ($)

$0.00

Total Sold ($)

$23.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 08HENDERSON MICHAEL THOMASdirectorSell33,513$73.72132,689
Fri May 08HENDERSON MICHAEL THOMASdirectorSell24,814$74.76107,875
Fri May 08HENDERSON MICHAEL THOMASdirectorSell19,269$75.3588,606
Fri May 08HENDERSON MICHAEL THOMASdirectorSell2,404$72.57166,202
Fri May 01Sloan Sheldonofficer: Chief Medical OfficerSell21,306$69.5357,027
Fri May 01Sloan Sheldonofficer: Chief Medical OfficerSell19,656$70.6137,371
Fri May 01Sloan Sheldonofficer: Chief Medical OfficerSell12,777$72.9415,817
Fri May 01Sloan Sheldonofficer: Chief Medical OfficerSell10,358$73.745,459
Fri May 01Sloan Sheldonofficer: Chief Medical OfficerSell8,777$71.5628,594
Fri May 01Sloan Sheldonofficer: Chief Medical OfficerSell78,333$27.46321,667
Fri May 01Burrows Scott Lofficer: Chief Financial OfficerSell12,500$71.3797,994
Fri May 01Burrows Scott Lofficer: Chief Financial OfficerSell12,500$14.50382,357
Fri Apr 03Turtle Camerondirector, officer: Chief Executive OfficerSell12,344$49.20630,196
Fri Apr 03Turtle Camerondirector, officer: Chief Executive OfficerSell2,656$49.92627,540
Fri Apr 03Sloan Sheldonofficer: Chief Medical OfficerSell7,958$50.000